Literature DB >> 32941703

The case of a 37-year-old male with trouble ambulating and incontinence.

Danny Bega1.   

Abstract

A 37 year-old previously healthy man from Jamaica presented with 2-3 months of progressive trouble ambulating and incontinence. By 1 month prior to arrival he was wheelchair bound and unable to ambulate even with assistance. He started to wear a diaper for bladder and bowel incontinence. He also complained of painless numbness in his legs over the same period of time. His exam is notable for marked weakness and spasticity in his legs, with hyper-reflexia and clonus. He has a sensory level at the level of the umbilicus. An MRI shows a longitudinally extensive T2 signal change throughout the thoracic cord. His cerebrospinal fluid is mildly inflammatory. His HTLV-1 antibody test is reactive.
© 2020 The Authors. Annals of Clinical and Translational Neurology published by Wiley Periodicals, Inc on behalf of American Neurological Association.

Entities:  

Year:  2020        PMID: 32941703      PMCID: PMC7545598          DOI: 10.1002/acn3.51180

Source DB:  PubMed          Journal:  Ann Clin Transl Neurol        ISSN: 2328-9503            Impact factor:   4.511


Diagnosis

Tropical Spastic Paraparesis

Take‐Home Points

HTLV is an oncogenic retrovirus associated with Adult T‐cell Leukemia/Lymphoma, Myelopathy, and Uveitis. HTLV‐1 is endemic to Japan, Africa, Cental/South America, and the Caribbean. In each of these locations, at least 5% of the population carries the virus. The virus is passed through sexual intercourse, blood transfusions, and in the peripartum or nursing period. HTLV can cause insidious onset of spastic paraparesis and bladder dysfunction without remissions. Treatment is supportive and symptomatic. Prevention is essential. , (Fig. 1)
Figure 1

T2 hyper‐intense signal is seen throughout the thoracic spinal cord with cord edema most pronounced at the mid‐thoracic region.

T2 hyper‐intense signal is seen throughout the thoracic spinal cord with cord edema most pronounced at the mid‐thoracic region.
  2 in total

Review 1.  Epidemiology, treatment, and prevention of human T-cell leukemia virus type 1-associated diseases.

Authors:  Denise Utsch Gonçalves; Fernando Augusto Proietti; João Gabriel Ramos Ribas; Marcelo Grossi Araújo; Sônia Regina Pinheiro; Antônio Carlos Guedes; Anna Bárbara F Carneiro-Proietti
Journal:  Clin Microbiol Rev       Date:  2010-07       Impact factor: 26.132

2.  Infectious myelopathies.

Authors:  Tracey A Cho; Henrikas Vaitkevicius
Journal:  Continuum (Minneap Minn)       Date:  2012-12
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.